Keytruda will exceed $30 billion in sales in 2028, according to a new projection by Evaluate, and that doesn’t include the sales of the cancer drug’s subcutaneous formulation, which are estimated by then to reach $2.4 billion. (Merck & Co.)Despite all the upheaval in the pharma industry over the last few years, many familiar names […]
